Skip to Main Content
Insider Trading

Kathleen M Whalen Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 1 week ago

Kathleen M Whalen has an estimated net worth of at least $10.1 million*, as of Dec. 18, 2024. They own 9,454 shares of HCA stock. They have sold 23,642 shares of HCA stock since 2021, for an estimated $7.2 million.

Kathleen M Whalen $HCA SEC Form 4 Insider Trading

Kathleen M Whalen has filed a total of 10 insider trades in $HCA since 2021. Their most recent trade was a sale of 1,474 shares, made on Nov 14, 2024. Their largest trade was a sale of 4,262 shares, made on Feb 09, 2024. We estimate that they now own 9,454 shares of $HCA, worth an estimated $2.9 million.



Insider Trading at $HCA

There have been a total of 96 insider trades reported at $HCA since 2021, with 91,695 shares purchased and 488,240 shares sold. The most active insider traders in $HCA stock have been Kathryn A. Torres, Kathleen M Whalen, and Michael S. Cuffe. The most recent trade was a sale of 1,474 shares reported by Kathleen M Whalen (SVP & Chief Ethics Officer), made on Nov 14, 2024.



History of Insider Stock Trades by Kathleen M Whalen

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
HCA Sale 1,474 Nov 14, 2024 Nov. 18, 2024, 6:50 p.m.
HCA Sale 2,987 Jul 31, 2024 July 31, 2024, 5:44 p.m.
HCA Sale 1,864 Jul 29, 2024 July 31, 2024, 5:44 p.m.
HCA Sale 3,204 May 16, 2024 May 20, 2024, 5:23 p.m.
HCA Sale 4,262 Feb 09, 2024 Feb. 13, 2024, 8:03 p.m.
HCA Sale 2,916 Aug 03, 2023 Aug. 7, 2023, 4:39 p.m.
HCA Sale 1,734 Feb 17, 2023 Feb. 22, 2023, 9:10 p.m.
HCA Sale 500 May 03, 2022 May 5, 2022, 5:05 p.m.
HCA Sale 3,815 Nov 04, 2021 Nov. 3, 2021, 8 p.m.
HCA Sale 886 Jul 22, 2021 July 25, 2021, 8 p.m.




$HCA Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.